Zydus Wellness Limited has officially notified stock exchanges about its upcoming Board of Directors meeting scheduled for Tuesday, February 3, 2026. The meeting will focus on approving the company's unaudited financial results for the third quarter of fiscal year 2026, covering the quarter and nine months ended December 31, 2025.

Regulatory Compliance and Meeting Details

The company has issued formal notices to both BSE Limited and the National Stock Exchange of India Limited, adhering to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Nandish P. Joshi, Company Secretary & Compliance Officer, on January 21, 2026.

Trading Window Restrictions

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, Zydus Wellness has implemented a trading window closure for its Directors and Designated Persons. The restrictions will be effective until the financial results are made public.

Meeting Agenda

While the primary focus of the Board meeting will be the approval of Q3FY26 unaudited financial results, the company has indicated that other agenda items will also be considered during the session. The financial results will cover both the quarterly performance for the three months ended December 31, 2025, and the cumulative nine-month performance for the same period.

The scheduled Board meeting represents a routine corporate governance practice, ensuring timely disclosure of financial performance to stakeholders and maintaining transparency in line with regulatory requirements.

Zydus Wellness Limited has secured significant legal relief for its wholly owned subsidiary regarding a substantial GST demand, with the Gujarat High Court providing interim protection against enforcement proceedings.

Court Grants Interim Relief

The Gujarat High Court granted ad-interim relief to Zydus Wellness Products Limited (ZWPL) on January 9, 2026, restraining further proceedings related to a GST demand case. The court's decision came during a hearing for a writ petition filed under Article 226 of the Constitution of India, challenging an Order-in-Original (OIO) dated September 30, 2025.

GST Demand Details

The case involves a significant financial exposure for the Zydus Wellness subsidiary:

The Directorate General of Goods and Services Tax Intelligence, Surat Zonal Unit (DGGI) had issued the demand through a Show Cause Notice (SCN) and subsequent Order-in-Original, alleging GST liability along with applicable interest and penalty components.

Indemnification Coverage

A crucial aspect of this case is the indemnification arrangement covering the disputed period. The GST demand relates to the pre-acquisition period prior to January 30, 2019, and the liability stands fully indemnified by Heinz Italia S.P.A. This indemnification provides financial protection to Zydus Wellness against the potential liability arising from the disputed GST demand.

Regulatory Compliance

Zydus Wellness Limited has maintained transparency regarding this matter through regular disclosures to stock exchanges. The company referenced earlier disclosures dated October 29, 2025, February 27, 2025, and December 25, 2024, demonstrating consistent compliance with SEBI regulations regarding material developments.

The current disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with relevant SEBI Master Circulars. This regulatory framework ensures investors remain informed about significant legal and financial developments affecting the company and its subsidiaries.

The ad-interim relief provides temporary protection for ZWPL while the legal challenge proceeds through the judicial system, offering the subsidiary breathing room from enforcement actions during the ongoing litigation process.